Clinical Trial Update: Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares ultrashort psychotherapy to sustained-release bupropion for smoking cessation; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Substance Abuse
• Substance Dependence
• Tobacco Dependence

Drugs mentioned

• Sustained-Release Bupropion (bupropion)
• Ultrashort Psychotherapy

Snippet

Sponsor: Medical University Innsbruck | Conditions: Nicotine Dependence, Substance Abuse | Phase 4 | Status: COMPLETED